freya.submit

Introduction

The pharmaceutical regulatory landscape has never been more complex. With evolving guidelines across regions, voluminous data requirements, and relentless timelines, submission teams are stretched thin-often leading to costly errors, delays in market access, and regulatory pushbacks. Enter artificial intelligence (AI): a game-changer poised to transform how life sciences organizations prepare, validate, and file submissions.